MedPath

Acquired Von Willebrand Syndrome in Severe Aortic Stenosis

Completed
Conditions
Bleeding
Von Willebrand Disease
Aortic Stenosis
Registration Number
NCT00805051
Lead Sponsor
University Hospital, Basel, Switzerland
Brief Summary

Patients with severe aortic stenosis often suffer from an acquired Von Willebrand syndrome by degeneration of the polymers during passage through the narrow valve leading to turbulences. We hypothesized that the diagnosis of acquired von Willebrand syndrome influence perioperative blood loss in patients undergoing open cardiac valve replacement.

Detailed Description

Patients with severe aortic stenosis often suffer from an acquired Von Willebrand syndrome by degeneration of the polymers during passage through the narrow valve leading to turbulences. After written consent and an extended anamnesis of existing coagulopathy, we take three blood samples in these patients: before surgery, on the day after surgery and 4 weeks after surgery. We determine von Willebrand factor in lab and by a point-of-care platelet function analyzer (Multiplate TM). We measure amount of mediastinal drainage after 24 hours and blood product consumption in these patients.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Severe aortic stenosis (Orifice area < 1 cm2)
Exclusion Criteria
  • missing consent
  • severe hepatic or renal disfunction

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Amount of mediastinal drainage in the first 24 hours24 hours
Secondary Outcome Measures
NameTimeMethod
Amount of given blood products in the first 24 hours24 hours

Trial Locations

Locations (1)

Department of Anaesthesia, University of Basel Hospital

🇨🇭

Basel, Switzerland

© Copyright 2025. All Rights Reserved by MedPath